NHS Secures Bone Cement Rescue Package So Joint Surgery Can Resume

Published: 25 February 2026 . The English Chronicle Desk. The English Chronicle Online

The National Health Service in the United Kingdom has secured an emergency supply of bone cement, allowing hospitals to resume thousands of postponed joint operations after a critical shortage threatened to disrupt hip and knee replacements nationwide. The rescue package comes after the NHS’s main supplier encountered a production failure that had left services with only limited reserves, forcing trusts to delay hundreds of procedures while prioritising urgent trauma care.

Bone cement is a specialised medical material used to secure prosthetic joints — particularly in hip and knee surgeries — and is essential for more than 1,000 operations each week under the NHS. Earlier this month, Germany‑based manufacturer Heraeus Medical, which supplies the bulk of the NHS’s bone cement, halted production at its main plant due to a critical machine failure, triggering concerns that planned joint surgery would grind to a halt for up to eight weeks or more.

As a result of those disruptions, hospitals across England and other parts of the UK were forced to prioritise patients with urgent needs, such as older people requiring emergency treatment after falls, and postpone elective procedures for those on long waiting lists. Trusts including Cambridge University Hospitals had acknowledged that some planned joint replacements would need to be deferred until supplies stabilised.

Officials now say the shortfall will be covered after the NHS sourced an alternative bone cement supply from Dutch manufacturer Zimmer Biomet, securing enough material to cover 10–12 weeks of operations, with the first shipments already delivered. Another existing supplier, Johnson & Johnson, has also agreed to boost its deliveries.

Professor Tim Briggs of NHS England described the rescue package as “extremely concerning” but a significant step in safeguarding care. He said the additional supplies should allow trauma and elective orthopaedic surgery to continue across the country while the main supplier restores full production.

Doctors and patient groups have welcomed the news, noting that alternative bone cement products have been widely used in Europe and are considered comparable in quality and safety. Fergal Monsell, representing the British Orthopaedic Association, reassured patients that the alternative cement has undergone clinical assessment and should not affect surgical outcomes.

Health minister Zubir Ahmed said the government’s priority is to cut waiting lists and minimise disruption to patient care. He indicated that the focus will now shift to rescheduling postponed operations and ensuring that patients waiting for joint replacements are treated as quickly as possible.

Although the production issue at Heraeus’s German plant is expected to continue affecting supply temporarily, the new rescue package and expanded deliveries from other manufacturers should ease pressure on NHS orthopaedic services in the coming months.

Read More At>>